Our Innovative Medicines business is made up of two commercial units: Innovative Medicines International and Innovative Medicines US.

Core therapeutic areas

We focus on five core therapeutic areas with high unmet patient needs.

  • Cardiovascular

    Cardiovascular disease is a global health crisis. Billions of people are affected physically, emotionally and financially. Thanks to a combination of our legacy, global footprint and leading science, Novartis is uniquely positioned to help change this landscape. Our efforts include use of early interventions and development of pioneering treatments, from prevention to management, as well as the creation of innovative access models. Our goal is to reduce and ultimately stop premature death and disability from cardiovascular disease.
  • Hematology

    Novartis is deeply committed to transforming the lives of people living with blood cancers and life-threatening blood disorders. Together with its research partners – Novartis led the era of targeted therapies in cancer and, in investigating how these medicines could transform patient outcomes.
  • Solid tumors

    Novartis is pushing the limits of science to discover and develop next-generation therapeutics that may provide meaningful outcomes for patients with the most prevalent and deadliest cancers.
  • Immunology

    Novartis aims to improve outcomes and enhance the lives of those affected by painful and debilitating immunological conditions. As a result, we have already helped transform the standard of care for children and adults suffering from conditions such as psoriatic disease and axial spondyloarthritis, chronic urticaria, and a number of rare autoinflammatory diseases. We continue to focus on discovering and delivering innovative medicines for complex, less-explored immunological diseases where there is significant unmet need, such as hidradenitis suppurativa and Sjögren’s syndrome, lupus and osteoarthritis.
  • Neuroscience

    Novartis has been tackling neurological conditions for more than 80 years. Above all, partnering with patients, healthcare professionals and healthcare systems to deliver life-changing solutions and treatments is at the core of what we do. Together, we can innovate to reimagine neuroscience and improve people’s lives.

In addition, we have research and in-market programs in the following therapeutic areas:


Novartis is reimagining the treatment and prevention of visual impairment and blindness. We aim to develop life-changing pharmaceuticals and transformative technologies for diseases and conditions from front to back of the eye.


At Novartis, our focus is on improving the lives of the hundreds of millions of people living with respiratory diseases, including chronic obstructive pulmonary disease (COPD) and severe allergic asthma.


Novartis Global Product Portfolio and Clinical Pipeline


Countries in which products are available


New molecular entities in our global clinical pipeline

Understanding hidradenitis suppurativa through Jasmine’s eyes

Jasmine, an HS advocate, journalist and filmmaker, is one of the estimated 1 in 100 of the global population who lives with this debilitating skin disease. HS has affected every aspect of her life since she was a child.

Solving the puzzle of immunotherapy

The question of how to unlock the potential of the body’s own immune system to kill cancer cells is more than a century old. At Novartis, we are building on insight to unlock the potential of immunotherapies for more patients around the world.

A Cell Processing Specialist at work in Novartis’ new cell and gene production facility in Stein, Switzerland.

Novartis Gene Therapies

Novartis Gene Therapies is dedicated to developing and commercializing gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases.

Innovative Medicines leadership

Marie-France Tschudin, President, Innovative Medicines International & Chief Commercial Officer
President, Innovative Medicines International and Chief Commercial Officer
Marie-France Tschudin
Victor Bulto,  President, Innovative Medicines US
President, Innovative Medicines US
Victor Bulto



Jobs in Innovative Medicines